Frédéric Legros
Chief Executive Officer at ARTHEx Biotech SL
Profile
Frédéric Legros is currently the Executive Chairman & Chief Executive Officer at ARTHEx Biotech SL and the Chairman at Anoat Therapeutics SAS.
Previously, he worked as a Director at BliNK Biomedical SAS, Vice President-Business Development at Valneva SE from 2015 to 2017, Chief Operating Officer at Dynacure SA from 2017 to 2022, and Manager at Cnrs Innovation SA from 2003 to 2005.
Dr. Legros obtained his undergraduate degree from NEOMA Business School.
Frédéric Legros active positions
Companies | Position | Start |
---|---|---|
ARTHEx Biotech SL
ARTHEx Biotech SL Miscellaneous Commercial ServicesCommercial Services ARTHEx Biotech S.L. engages in the development of antisense RNA (ribonucleic acid) treatments against genetic diseases. It offers Anti-microRNAs for the treatment of unmet genetic diseases. The company was founded by Beatriz Llamus? and Rub?n Artero on September 27, 2019 and is headquartered in Paterna, the United Kingdom. | Chief Executive Officer | 03/05/2023 |
Anoat Therapeutics SAS
Anoat Therapeutics SAS BiotechnologyHealth Technology Anoat Therapeutics SAS develops novel therapies for cystic fibrosis. The company is based in Paris, France. The French company was founded in 2023. Vincent Bischoff has been the CEO of the company since 2023. | Chairman | 25/03/2023 |
Former positions of Frédéric Legros
Companies | Position | End |
---|---|---|
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Chief Operating Officer | 01/10/2022 |
VALNEVA | Corporate Officer/Principal | 01/01/2017 |
Cnrs Innovation SA
Cnrs Innovation SA Miscellaneous Commercial ServicesCommercial Services CNRS Innovation SA is a French company that focuses on research and innovation. The company is based in Boulogne-Billancourt, France. The company has been in the industry for over 30 years and have a team of experts who provide services to clients. The company has signed numerous operating contracts since 2012 and has supported many start-ups since 2019. The company has subsidiaries and are ultimately controlled by the Centre National de la Recherche Scientifique. | Corporate Officer/Principal | 01/10/2005 |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Director/Board Member | - |
Training of Frédéric Legros
NEOMA Business School | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VALNEVA | Health Technology |
Private companies | 5 |
---|---|
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Health Technology |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Health Services |
Cnrs Innovation SA
Cnrs Innovation SA Miscellaneous Commercial ServicesCommercial Services CNRS Innovation SA is a French company that focuses on research and innovation. The company is based in Boulogne-Billancourt, France. The company has been in the industry for over 30 years and have a team of experts who provide services to clients. The company has signed numerous operating contracts since 2012 and has supported many start-ups since 2019. The company has subsidiaries and are ultimately controlled by the Centre National de la Recherche Scientifique. | Commercial Services |
ARTHEx Biotech SL
ARTHEx Biotech SL Miscellaneous Commercial ServicesCommercial Services ARTHEx Biotech S.L. engages in the development of antisense RNA (ribonucleic acid) treatments against genetic diseases. It offers Anti-microRNAs for the treatment of unmet genetic diseases. The company was founded by Beatriz Llamus? and Rub?n Artero on September 27, 2019 and is headquartered in Paterna, the United Kingdom. | Commercial Services |
Anoat Therapeutics SAS
Anoat Therapeutics SAS BiotechnologyHealth Technology Anoat Therapeutics SAS develops novel therapies for cystic fibrosis. The company is based in Paris, France. The French company was founded in 2023. Vincent Bischoff has been the CEO of the company since 2023. | Health Technology |
- Stock Market
- Insiders
- Frédéric Legros